Palonosetron hydrochloride and Thrombocytopenia - a phase IV clinical study of FDA data

Summary:

Thrombocytopenia is reported as a side effect among people who take Palonosetron hydrochloride (palonosetron hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Carboplatin, and have Nausea.

The phase IV clinical study analyzes which people have Thrombocytopenia when taking Palonosetron hydrochloride. It is created by eHealthMe based on reports of 2,083 people who have side effects when taking Palonosetron hydrochloride from the FDA, and is updated regularly.

What is Palonosetron hydrochloride?

Palonosetron hydrochloride has active ingredients of palonosetron hydrochloride. eHealthMe is studying from 2,088 Palonosetron hydrochloride users. Check the latest studies of Palonosetron hydrochloride.

What is Thrombocytopenia?

Thrombocytopenia (decrease of platelets in blood) is found to be associated with 2,792 drugs and 4,869 conditions by eHealthMe. Check the latest studies of Thrombocytopenia.

On May, 29, 2026

2,083 people reported to have side effects when taking Palonosetron hydrochloride.
Among them, 200 people (9.6%) have Thrombocytopenia.

Could Palonosetron hydrochloride cause Thrombocytopenia?

Among these 200 people:

How long have people been on Palonosetron hydrochloride when they have Thrombocytopenia? *

Click here to view more results

What is the gender of people who have Thrombocytopenia when taking Palonosetron hydrochloride? *

Click here to view

What is the age of people who have Thrombocytopenia when taking Palonosetron hydrochloride? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Palonosetron hydrochloride and have Thrombocytopenia?

- Check whether Thrombocytopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Palonosetron hydrochloride:

Palonosetron hydrochloride (2,088 reports)

Thrombocytopenia treatments and more:

Thrombocytopenia (285,083 reports)

How severe was Thrombocytopenia and when was it recovered:

Thrombocytopenia in Palonosetron hydrochloride

Expand to all the drugs that have ingredients of palonosetron hydrochloride:

Thrombocytopenia and drugs with ingredients of palonosetron hydrochloride (965 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Palonosetron hydrochloride:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Thrombocytopenia:

Thrombocytopenia (2,792 drugs)

Browse all the conditions that are associated with Thrombocytopenia:

Thrombocytopenia (4,869 conditions)

Related publications that referenced our studies

YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .
YavasogluI, I., TurgutkayaII, A., & BolamanIII, Z., "Chlorella-induced thrombocytopenia", DATA, 2018 Jan .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Onder H, Arsava EM, Arat A, Topcuoglu MA, "Acute middle cerebral artery occlusion treated by thrombectomy in a patient with myelodysplastic syndrome and severe thrombocytopenia", Journal of vascular and interventional neurology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on palonosetron hydrochloride (the active ingredients of Palonosetron hydrochloride) and Palonosetron hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.